252 related articles for article (PubMed ID: 30011277)
1. Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
Zivcec M; Safronetz D; Scott DP; Robertson S; Feldmann H
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006628. PubMed ID: 30011277
[TBL] [Abstract][Full Text] [Related]
2. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
3. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
[TBL] [Abstract][Full Text] [Related]
4. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.
Dowall SD; Buttigieg KR; Findlay-Wilson SJ; Rayner E; Pearson G; Miloszewska A; Graham VA; Carroll MW; Hewson R
Hum Vaccin Immunother; 2016; 12(2):519-27. PubMed ID: 26309231
[TBL] [Abstract][Full Text] [Related]
5. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
[TBL] [Abstract][Full Text] [Related]
6. Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach.
Tahir Ul Qamar M; Ismail S; Ahmad S; Mirza MU; Abbasi SW; Ashfaq UA; Chen LL
Front Immunol; 2021; 12():669812. PubMed ID: 34220816
[TBL] [Abstract][Full Text] [Related]
7. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
[TBL] [Abstract][Full Text] [Related]
8. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.
Keshtkar-Jahromi M; Kuhn JH; Christova I; Bradfute SB; Jahrling PB; Bavari S
Antiviral Res; 2011 May; 90(2):85-92. PubMed ID: 21362441
[TBL] [Abstract][Full Text] [Related]
9. The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain.
Papa A; Papadimitriou E; Christova I
Scand J Infect Dis; 2011 Mar; 43(3):225-9. PubMed ID: 21142621
[TBL] [Abstract][Full Text] [Related]
10. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Crimean-Congo hemorrhagic fever virus in healthy population, livestock and ticks in Kosovo.
Fajs L; Humolli I; Saksida A; Knap N; Jelovšek M; Korva M; Dedushaj I; Avšič-Županc T
PLoS One; 2014; 9(11):e110982. PubMed ID: 25393542
[TBL] [Abstract][Full Text] [Related]
12. A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.
Buttigieg KR; Dowall SD; Findlay-Wilson S; Miloszewska A; Rayner E; Hewson R; Carroll MW
PLoS One; 2014; 9(3):e91516. PubMed ID: 24621656
[TBL] [Abstract][Full Text] [Related]
13. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.
Zivcec M; Safronetz D; Scott D; Robertson S; Ebihara H; Feldmann H
J Infect Dis; 2013 Jun; 207(12):1909-21. PubMed ID: 23417661
[TBL] [Abstract][Full Text] [Related]
14. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.
Kempster S; Hassall M; Graham V; Kennedy E; Findlay-Wilson S; Salguero FJ; Bagci B; Elaldi N; Oz M; Tasseten T; Charlton FW; Barr JN; Fontana J; Duru C; Ezeajughi E; Matejtschuk P; Arnold U; Adedeji Y; Mirazimi A; Hewson R; Dowall S; Almond N
Virus Res; 2024 Aug; 346():199409. PubMed ID: 38815869
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses.
Dowall SD; Graham VA; Rayner E; Hunter L; Watson R; Taylor I; Rule A; Carroll MW; Hewson R
PLoS One; 2016; 11(6):e0156637. PubMed ID: 27272940
[TBL] [Abstract][Full Text] [Related]
16. Development of vaccines against Crimean-Congo haemorrhagic fever virus.
Dowall SD; Carroll MW; Hewson R
Vaccine; 2017 Oct; 35(44):6015-6023. PubMed ID: 28687403
[TBL] [Abstract][Full Text] [Related]
17. Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana.
Akuffo R; Brandful JA; Zayed A; Adjei A; Watany N; Fahmy NT; Hughes R; Doman B; Voegborlo SV; Aziati D; Pratt D; Awuni JA; Adams N; Dueger E
BMC Infect Dis; 2016 Jul; 16():324. PubMed ID: 27392037
[TBL] [Abstract][Full Text] [Related]
18. Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.
Kortekaas J; Vloet RP; McAuley AJ; Shen X; Bosch BJ; de Vries L; Moormann RJ; Bente DA
Vector Borne Zoonotic Dis; 2015 Dec; 15(12):759-64. PubMed ID: 26684523
[TBL] [Abstract][Full Text] [Related]
19. Molecular and serological findings in suspected patients with Crimean-Congo hemorrhagic fever virus in Iran.
Karlberg H; Sharifi-Mood B; Mousavi-Jazi M; Dilcher M; Lindegren G; Mardani M; Bereskly S; Weidmann M; Mirazimi A
J Med Virol; 2015 Apr; 87(4):686-93. PubMed ID: 25649667
[TBL] [Abstract][Full Text] [Related]
20. [Crimean-Congo hemorrhagic fever].
Saijo M; Moriikawa S; Kurane I
Uirusu; 2004 Dec; 54(2):223-7. PubMed ID: 15745160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
